Prostate Cancer Tx

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/91

encourage image

There's no tags or description

Looks like no tags are added yet.

92 Terms

1
New cards

2nd

Prostate cancer is the _______ most common malignancy of males in the US.

2
New cards

increases

Risk of prostate cancer __________ with age

3
New cards

66

What is the avg age of dx of prostate cancer?

4
New cards

black

There is an increased incidence of prostate cancer with ______ males

5
New cards

1 out of 8

__________ get dx with prostate cancer in their lifetime

6
New cards

prostate gland

heart shaped under bladder

7
New cards

BPH

is not a precursor for prostate cancer

8
New cards

5- alpha reducatase

Testosterone -> ____________ -> DHT

9
New cards

peripheral zone

most easily palpated and cells for prostate cancer mature here 1st

10
New cards

DHT

androgenic receptors are more sensitive to ________

11
New cards

LHRH

hypothalamus releases _________ that goes to the Pituitary.

12
New cards

LH and FSH

The pituitary releases ________ to the testes.

13
New cards

testosterone

The testes release _________ (95%) that is convered to DHT.

14
New cards

1) predisposing risk factors

2) cellular transformation

3) tumor development and progession

What are the pathways to prostate cancer?

15
New cards

predisposing risk factors for prostate cancer

-hereditary genetics: inherited mutations (BRCA1/2, HOXB13)

-age and epigenetics (accumulation of random DNA errors over time)

-environment and lifestyle (smoking, high fat diet, inflammation, obesity, hormonal imbalance)

16
New cards

cellular transformation pathway to prostate cancer

-oncogenes activated that increase cell multiplication

-fix damage or kill damaged cells

17
New cards

-self sufficiency in growth signals (AR driven)

-insensitivity to anti-growth signals

-tissue invasion and metastasis

-evading apoptosis

What are the hallmarks of prostate cancer?

18
New cards

digital rectal exam (DRE) and prostate specific antigen (PSA)

What are the screening for prostate cancer?

19
New cards

PSA

-useful for early detection

-useful for monitoring androgen-deprivation therapy or chemotherapy

20
New cards

earlier

Patients with increased risk may begin screens _________

21
New cards

< 4

Normal PSA:

22
New cards

> 10

Cancer PSA:

23
New cards

declining

There is a _________ rate of death with prostate cancer.

24
New cards

90%

What % of prostate cancer has early dx?

25
New cards

NIH-sponsored Prostate, Lung, Colorectal, and Ovarian (PLCO) screening trial

landmark trial

55-74 yo no evidence of mortality benefit in annual screenings for prostate cancer

26
New cards

age 50 is rec for avg screening (every 2-4 yrs)

STOP screening at 70

Preventative Services Task Force (USPSTF) recommendations for prostate cancer screening:

27
New cards

≥ 10 yrs

Pts who are getting screened for prostate cancer should have a life expectancy of _________

28
New cards

urology

abnormal PSA should be referred to ___________

29
New cards

stage 1 prostate cancer

-T1-2a

-N0

-M0

-tumor is small and cannot be detected through digital rectal examination (DRE)

30
New cards

stage 2

-T2b-c

-N0

-M0

-the cancerous tissue is larger, but still be confined within the prostate

31
New cards

stage 3

-T3

-N0

-M0

-the cancer has invaded surrounding tissues

32
New cards

Stage 4

-T4

-N1

-M1

-the cancer has spread to lymph nodes, bones, or other distant parts of the body beyond the pelvic region

33
New cards

< 10

PSA level in stage 1:

34
New cards

10-19.9

PSA level in stage 2a:

35
New cards

≥ 20

PSA level in stage 2b:

36
New cards

any

PSA level in stage 3 and 4:

37
New cards

gleason score

-Grading scale for prostate cancer cells

-Ranges 2-10

-Indicative of how likely a tumor is to spread

38
New cards

low/very low

gleason score ≤ 6

39
New cards

intermediate (favorable/unfavorable)

Gleason Score 7 (3+4)

Gleason Score 7 (4+3)

40
New cards

high/very high

Gleason Score 8

Gleason Score 9-10

41
New cards

2

There are ____ gleason score samples taken in a biopsy.

42
New cards

well differentiated

gleason's pattern scale 1

43
New cards

3+ gleasons pattern scale

poorly differentiated anaplastic

44
New cards

1) observation

2) radiation

3) radical prostatectomy

Tx for TNM stage T1 or T2a; Gleason ≤ 6; PSA < 10

45
New cards

1) observation

2) Radical prostatectomy w/ pelvic lymph node dissection

3) Radiation therapy +/- ADT +/- brachytherapy

Tx for TNM stage T2b-T2c; Gleason 7; PSA 10-20:

46
New cards

1) Radiation therapy + ADT +/- brachytherapy

2) Radical prostatectomy w/ pelvic lymph node dissection

Tx for TNM stage T3a; Gleason 8-10; PSA > 20:

47
New cards

1) Radiation therapy + ADT +/- brachytherapy

2) Radical prostatectomy w/ pelvic lymph node dissection

3) ADT

Tx for TNM stage T3b-T4; gleason > 4 scores of 8-10:

48
New cards

-watchful waiting

-surgery

-radiation

What are the non-med tx options for prostate cancer?

49
New cards

Watchful Waiting

for asymptomatic patients or patients who cannot tolerate treatment

50
New cards

surgery

-prostatectomy

-possible pelvic lymph node dissection

-bilateral orchiectomy (removal of testes)

51
New cards

radiation

2 general types

-External beam radiotherapy

-Brachytherapy: implantation of radioactive beads

52
New cards

LUTEINIZING HORMONE-RELEASING HORMONE AGONISTS

-affective for prostate cancer

-neg feedback control tells pituitary to stop releasing LH/FSH (bottoms out)

-1st 2 weeks more s/s due to DHT surge but after it bottoms out due to neg feedback loop

53
New cards

Currently available LH-RA:

-Lupron (leuprolide) daily

-Lupron Depot (leuprolide depot) 1-6 months

-Viadur (leuprolide intradermal implant) 12 months

-Trelstar Depot (triptorelin depot) 4 weeks

-Trelstar LA (triptorelin) 12 weeks

-Zoladex (goserelin subcutaneous implant) 28 days

54
New cards

-Disease flare-up during first week of therapy caused by initial induction of LH and FSH

-Hot flashes

-Impotence

-Decreased libido

-Injection site reactions

LH-RA AEs:

55
New cards

80%

LH-RH agonists have response rates as high as _______

56
New cards

GONADOTROPIN-RELEASING HORMONE ANTAGONISTS

-bind to GnRH receptors and antagonize pituitary

-no flare up

-castrate levels of testosterone in 1 week

57
New cards

GnRH antagoinsts

-Used as an alternative to LH-RH agonists

-Similar MOA in that it reduces testosterone production to castrate levels

58
New cards

Lupron

Leuprolide

59
New cards

Lupron Depot

leuprolide depot

60
New cards

Viadur

leuprolide intradermal implant)

61
New cards

Trelstar Depot

triptorelin depot)

62
New cards

Trelstar LA

triptorelin

63
New cards

Zoladex

goserelin subcutaneous implant

64
New cards

Firmagon

degrelix for injection

65
New cards

Orgovyx

relugolix tabs

66
New cards

-Hot flashes

-Fatigue, tiredness

-Muscle/joint pain

-Decreased libido

-Injection site reactions

-QT prolongation

-Bone mineral density loss

Degarelix AEs:

67
New cards

-Hot flashes

-Fatigue, tiredness

-Muscle/joint pain

-Decreased libido

-Hyperglycemia

-Hypertriglyceridemia

-CYP 3A4 substrate

-QT prolongation

-Bone mineral density loss

Relugolix AEs:

68
New cards

ANTIANDROGENS

block androgen receptors from binding androgens

69
New cards

1st Generation Antiandrogens

-Eulexin (flutamide) 750mg/day

-Casodex (bicalutamide) 50mg/day

-Nilandron (nilutamide) 300mg/day 1st month; 150mg/day thereafter

70
New cards

2nd generation Antiandrogens

-Erleada (apalutamide)

-Xtandi (enzalutamide)

-Nubeqa (darolutamide)

71
New cards

Eulexin

flutamide

72
New cards

Casodex

bicalutamide

73
New cards

Nilandron

nilutamide

74
New cards

Erleada

apalutamide

75
New cards

Xtandi

enzalutamide

76
New cards

Nubeqa

darolutamide

77
New cards

abiraterone acetate

inhibits synthesis

78
New cards

Erleada

apalutamide

79
New cards

casodex (bicalutamide)

-Only 1st gen antiandrogen still available

-good med to start prior to LH-RH agonist (flare up)

80
New cards

full

2nd gen antiandrogens are _____ antagonists (very effective)

81
New cards

Erleada

Apalutamide

82
New cards

Apalutamide (Erleada)

-240 mg orally daily

-AE: hypothyroidism, rash, falls, fractures

83
New cards

Enzalutamide (Xtandi)

-160 mg orally daily

-AE: serizures/mental impairment, CV events, fatigue, falls

84
New cards

Darolutamide (Nubeqa)

-600 mg orally twice daily with food

-AE: fatigue

85
New cards

no (CYP interaction)

Can you use Relngolix with antiandrogens?

86
New cards

NON-METASTATIC CASTRATE-RESISTANT PROSTATE CANCER (NMCRPC)

- Patients receive ADT x prolonged period

- Biochemical progression during this time despite serum testosterone concentration < 50 ng/dL and no s/sx metastasis

-≥ 25% increase PSA concentration; 3 weeks later- increased PSA is confirmed

-PSA doubling time ≤ 10 months: 2nd gen antiandrogens + ADT

87
New cards

over-dx and over-tx

What can widespread screening for prostate cancer lead to?

88
New cards

leads to urinary incontinence and ED (20-70%)

What is a possible complication of radical prostatectomy and radiation therapy?

89
New cards

-fever, pain, hematuria

-pos urine cultures, hematospermia

What are the complications from biopsy?

90
New cards

-5 alpha reductase inhibitors?

-Finasteride (Proscar)

-Dutasteride (Avodart)

NON FDA APPROVED FOR PREVENTION

What can be used as preventative for prostate cancer?

91
New cards

Proscar

Finasteride

92
New cards

Avodart

Dutasteride